Back to Skandinaviska Enskilda Banken AB (publ) Skandinaviska Enskilda Banken AB (publ)

VRTXVRTX
Showing 8 of 31 quarters

Position history for Skandinaviska Enskilda Banken AB (publ)Skandinaviska Enskilda Banken AB (publ)'s holdings in VERTEX PHARMACEUTICALS INC

Skandinaviska Enskilda Banken AB (publ) holds 23,000 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $11.4M as of 2026-Q2. The position was decreased (-50.0% shares). VRTX represents 0.4% of Skandinaviska Enskilda Banken AB (publ)'s portfolio.

Current Value

$11.4M

Current Shares

23,000

Total Value Change

-$74.8M

Total Shares Change

-162,285

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
23,000
-50.0%
$11.4M0.4%$496.73
0
2026-Q1
Decreased
46,000
-73.6%
$20.5M0.5%$474.27
0
2025-Q4
Increased
174,466
+13.1%
$79.1M0.3%$453.74
40
2025-Q3
Decreased
154,248
-12.7%
$60.4M0.2%$395.31
0
2025-Q2
Decreased
176,604
-5.3%
$78.6M0.3%$441.30
0
2025-Q1
Increased
186,471
+9.0%
$90.4M0.4%$492.69
39
2024-Q4
Decreased
171,034
-7.7%
$68.3M0.3%$399.35
0
2024-Q3
Decreased
185,285
-15.3%
$86.2M0.4%$462.88
0

Other major holders of VRTX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used